Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
- Horizon Discovery
- 8100 Cambridge Research Park
- Cambridge , CB25 9TL
- UNITED KINGDOM
Horizon Discovery is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them to advance human health. Horizon’s catalogue of over 23,000 models supports the understanding of the genetic drivers of disease, and underpins a broad range of services and Horizon’s own R&D pipeline.